William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 33,164 shares at $74.75 ($2.5M) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Scheduled sale ($2.5M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.75 | 6,536 | $489K | 19.5% |
| 2 | $75.64 | 13,164 | $996K | 39.8% |
| 3 | $75.64 | 13,164 | $996K | 39.8% |
| 4 | $76.28 | 300 | $23K | 0.9% |
| Total | $75.47 avg | 33,164 | $2.5M | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |